This statistic displays the projected 2018 revenue for top 10 drugs approved in the U.S. in 2013 . Tivicay , approved on August 12 , 2013 , and developed by GlaxoSmithKline , is estimated to generate 2.13 billion U.S. dollars in annual revenue in 2018 . Pharmaceutical and biotechnology companies experienced widespread growth worldwide with the United States garnering the largest growth .
